We have located links that may give you full text access.
Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues using PCT-SWATH.
Proteomics. Clinical Applications 2018 October 27
PURPOSE: To rapidly identify protein abundance changes in biopsy-level fresh-frozen hepatocellular carcinoma (HCC).
EXPERIMENTAL DESIGN: We applied the pressure-cycling technology (PCT) and optimized sequential window acquisition of all theoretical mass spectra (SWATH-MS) workflow to analyze 38 biopsy-level tissue samples from 19 HCC patients. Each proteome was analyzed with 45 min liquid chromatography (LC) gradient. MCM7 was validated using immunohistochemistry (IHC).
RESULTS: We quantified 11,787 proteotypic peptides from 2,579 SwissProt proteins with high confidence. The coefficient of variation (CV) of peptide yield using PCT was 32.9%, and the R2 of peptide quantification was 0.9729. 541 proteins showed significant abundance change between the tumor area and its adjacent benign area. From 24 upregulated pathways and 13 suppressed ones, we observed enhanced biomolecule synthesis and suppressed small molecular metabolism in liver tumor tissues. We further analyzed protein changes based on α-fetoprotein expression and HBV infection. Our data altogether highlighted 16 promising tumor marker candidates. The up-regulation of minichromosome maintenance complex component 7 (MCM7) was further observed in multiple HCC tumor tissues by IHC.
CONCLUSIONS AND CLINICAL RELEVANCE: We demonstrated the practicality of rapid proteomic analysis of biopsy-level fresh-frozen HCC tissue samples with PCT-SWATH and identified promising tumor marker candidates including MCM7. This article is protected by copyright. All rights reserved.
EXPERIMENTAL DESIGN: We applied the pressure-cycling technology (PCT) and optimized sequential window acquisition of all theoretical mass spectra (SWATH-MS) workflow to analyze 38 biopsy-level tissue samples from 19 HCC patients. Each proteome was analyzed with 45 min liquid chromatography (LC) gradient. MCM7 was validated using immunohistochemistry (IHC).
RESULTS: We quantified 11,787 proteotypic peptides from 2,579 SwissProt proteins with high confidence. The coefficient of variation (CV) of peptide yield using PCT was 32.9%, and the R2 of peptide quantification was 0.9729. 541 proteins showed significant abundance change between the tumor area and its adjacent benign area. From 24 upregulated pathways and 13 suppressed ones, we observed enhanced biomolecule synthesis and suppressed small molecular metabolism in liver tumor tissues. We further analyzed protein changes based on α-fetoprotein expression and HBV infection. Our data altogether highlighted 16 promising tumor marker candidates. The up-regulation of minichromosome maintenance complex component 7 (MCM7) was further observed in multiple HCC tumor tissues by IHC.
CONCLUSIONS AND CLINICAL RELEVANCE: We demonstrated the practicality of rapid proteomic analysis of biopsy-level fresh-frozen HCC tissue samples with PCT-SWATH and identified promising tumor marker candidates including MCM7. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app